Physician profile
Asaf Yalif
NPI 1467676718
$42,731.85
in general payments reported to CMS, 2019-2025
12 companies · $8,865 in 2025
The $8,865 reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,021 · 2020: $2,013 · 2021: $6,620 · 2022: $3,186 · 2023: $16K · 2024: $2,266 · 2025: $8,865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $2,135 · Travel and Lodging: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,425.00 |
| Food and Beverage | $2,134.63 |
| Travel and Lodging | $1,432.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $24,544.08 | 2020-2025 | Celleraterx, Celleraterx, Biasurge |
| Tela Bio, INC. | $15,831.43 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $1,234.68 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 4 Breast Tissue Expander |
| Axogen | $502.58 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $241.72 | 2019-2021 | |
| Acumed LLC | $109.73 | 2019 | |
| Wound Management Technologies, INC | $74.62 | 2019 | |
| Abbvie INC. | $54.09 | 2023-2024 | Botox |
| Galderma Laboratories, L.P. | $51.58 | 2021-2025 | |
| Revance Therapeutics, INC. | $42.40 | 2025 | Daxxify |
| Allergan, INC. | $26.50 | 2019 | |
| Integra Lifesciences Corporation | $18.44 | 2024 | Integra, Surgimend, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asaf Yalif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.